2nd Quarter - Report

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Firm
Client
Income
—
Expenses
$900,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and, S. 2123. and H.R. 5771, The Charitable Giving Tax Deduction Act. H.R. 1337, Legacy IRA Act respecting charitable giving and life income planning.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
RACHEL MARCUS —
CAROLINE POWERS —

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); White House Office; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Energy, Dept of; SENATE; U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID)

Bills named: H.R. 5771 (115th), H.R. 3988 (115th), H.R. 1337 (115th), S. 2123 (115th)

Health Issues HCR

Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests.

Contacted: U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA); Energy, Dept of; White House Office

Bills named: S. 204 (115th), S. 456 (115th), S. 497 (115th), H.R. 1028 (115th), S. 292 (115th), H.R. 772 (115th), H.R. 1231 (115th), H.R. 6 (115th), H.R. 1676 (115th), S. 693 (115th), H.R. 930 (115th), H.R. 1409 (115th), S. 261 (115th), H.R. 820 (115th), S. 1719 (115th), H.R. 878 (115th)

Medicare/Medicaid MMM

Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.HR 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
STEPHANIE KRENRICH New —
RACHEL MARCUS —
EMILY MYATT —
CAROLINE POWERS —
PHYLICIA L WOODS New —

Contacted: SENATE; Veterans Affairs, Dept of (VA); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); Energy, Dept of; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); State, Dept of (DOS); White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 6 (115th), S. 479 (115th), H.R. 1017 (115th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including: HR 1625, The Consolidated Approp. Act of 2018 respecting FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
RACHEL MARCUS —
CAROLINE POWERS —
EMILY WHITE —

Contacted: Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); State, Dept of (DOS); SENATE; Energy, Dept of; Health Resources & Services Administration (HRSA); White House Office; U.S. Agency for International Development (USAID)

Bills named: H.R. 1625 (115th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 and FY19 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
RACHEL MARCUS —
CAROLINE POWERS —

Contacted: HOUSE OF REPRESENTATIVES; Energy, Dept of; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); U.S. Agency for International Development (USAID); Veterans Affairs, Dept of (VA); U.S. Trade Representative (USTR); SENATE; Natl Institutes of Health (NIH); White House Office; Food & Drug Administration (FDA)

Bills named: H.R. 1662 (115th), H.R. 1136 (115th), S. 2100 (115th), S. 2119 (115th), H.R. 564 (115th), H.R. 1848 (115th), S. 1837 (115th), S. 294 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.